Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-17-007337

Director bought 2,692,307 shares at $2.60 ($6,999,998)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BROADWOOD PARTNERS, L.P. Director 2017-10-13 Purchase +2,692,307 $2.60 $6,999,998 29,971,561 D: show line 1 in the form
BROADWOOD PARTNERS, L.P. Director 2017-10-13 Purchase +0 29,971,561 I: show line 2 in the form
Open-market purchases · 2,692,307 sh · avg $2.60 · $6,999,998
Loading xslF345X03/p7683481.xml…